Acyclic tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia
申请人:Bristol-Myers Squibb Company
公开号:EP0476493A1
公开(公告)日:1992-03-25
This invention relates to structurally novel acyclic tocotrienol analogs, which are useful for cholesterol/lipid lowering in cases of hypercholesterolemia and hyperlipidemia, and for atherosclerosis. Also provided are pharmaceutical compositions and a method of use employing those compositions.
Acyclic Tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia
申请人:Bristol-Myers Squibb Company
公开号:EP0571928A1
公开(公告)日:1993-12-01
This invention relates to structurally novel acyclic tocotrienol analogs, which are useful for cholesterol/lipid lowering in cases of hypercholesterolemia and hyperlipidemia, and for atherosclerosis. Also provided are pharmaceutical compositions and a method of use employing those compositions.
v. Werder; Moll; Jung, Hoppe-Seyler's Zeitschrift fur Physiologische Chemie, 1939, vol. 257, p. 129,133
作者:v. Werder、Moll、Jung
DOI:——
日期:——
Tocotrienol analogs in the treatment of hypercholesterolemia and
申请人:Bristol-Myers Squibb Company
公开号:US05393776A1
公开(公告)日:1995-02-28
This invention relates to structurally novel acyclic tocotrienol analogs, which are useful for cholesterol/lipid lowering in cases of hypercholesterolemia and hyperlipidemia, and for atherosclerosis. Also provided are pharmaceutical compositions and a method of use employing those compositions.